Abstract #3854
Combined MR Volumetry and Diffusion Weighted imaging to better predict clinically significant prostate cancer on MRI/Ultrasound fused guided biopsy?
Stephanie Nougaret 1 , Nicola L Robertson 1 , Evis Sala 1 , Hedvik Hricak 1 , Behfar Ehdaie 2 , and Hebert A Vargas 1
1
Radiology department, Memorial Sloan
Kettering Cancer Center, New York, NY, United States,
2
Urology
department, Memorial Sloan Kettering Cancer Center, New
York, NY, United States
To evaluate the combined efficacy of MR Volumetry and
Diffusion Weighted Imaging (DWI), in the detection of
clinically significant prostate cancer using MRI-US
fusion biopsy. This preliminary study demonstrates the
potential added predictive value of using tumor
volumetry in combination with DWI, in the diagnosis of
clinically significant prostate cancer using MRI-US
fusion biopsy. Furthermore, it evaluates the feasibility
of quantitative assessment in tumor burden.
This abstract and the presentation materials are available to members only;
a login is required.
Join Here
